GI
JAZZ icon

Gradient Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gradient Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$640 – 836
2024
Q2 		$640 Hold
6
– – ﹤0.01% 1154
2024
Q1 		$723 Hold
6
– – ﹤0.01% 962
2023
Q4 		$738 Hold
6
– – ﹤0.01% 1505
2023
Q3 		$777 Hold
6
– – ﹤0.01% 1449
2023
Q2 		$744 Sell
6
-1
-14% -$135 ﹤0.01% 1448
2023
Q1 		$1.02K Hold
7
– – ﹤0.01% 1202
2022
Q4 		$1.11K Hold
7
– – ﹤0.01% 1175
2022
Q3 		$1K Hold
7
– – ﹤0.01% 1247
2022
Q2 		$1K Hold
7
– – ﹤0.01% 1139
2022
Q1 		$1K Hold
7
– – ﹤0.01% 1107
2021
Q4 		$1K Hold
7
– – ﹤0.01% 1157
2021
Q3 		$1K Hold
7
– – ﹤0.01% 1083
2021
Q2 		$1K Buy
+7
New +$1.21K ﹤0.01% 1081
2019
Q4 		– Sell
-16
Closed -$2K – 1160
2019
Q3 		$2K Buy
16
+8
+100% +$1.07K ﹤0.01% 930
2019
Q2 		$1K Buy
+8
New +$1.07K ﹤0.01% 954
2015
Q4 		– Sell
-2,368
Closed -$314K – 714
2015
Q3 		$314K Sell
2,368
-516
-18% -$88.8K 0.04% 150
2015
Q2 		$508K Sell
2,884
-31
-1% -$5.57K 0.07% 127
2015
Q1 		$504K Sell
2,915
-252
-8% -$43.2K 0.08% 129
2014
Q4 		$519K Buy
+3,167
New +$526K 0.09% 123

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Gradient Investments's JAZZ Position: Q3 2024 in Review

Gradient Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 6 shares — an estimated $640 sold.

Gradient Investments first reported a position in JAZZ in Q4 2014 and held it in 19 quarters. The position peaked at $519K in Q4 2014. 478 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Gradient Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 6 Jazz Pharmaceuticals shares in Q3 2024, an estimated $640.
  • Gradient Investments first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Gradient Investments's Jazz Pharmaceuticals position peaked at $519K in Q4 2014.
  • 478 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.